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Abstract
Background: Mobile technology interventions (MTI) are becoming increasingly popular in the management of chronic health
behaviors. Most MTI allow individuals to monitor medication use, record symptoms, or store and activate disease-management
action plans. Therefore, MTI may have the potential to improve low adherence to medication and action plans for individuals
with asthma, which is associated with poor clinical outcomes.
Objective: A systematic review and meta-analysis were conducted to evaluate the efficacy of MTI on clinical outcomes as well
as adherence in individuals with asthma. As the use of evidence-based behavior change techniques (BCT) has been shown to
improve intervention effects, we also conducted exploratory analyses to determine the role of BCT and engagement with MTI
as moderators of MTI efficacy.
Methods: We searched electronic databases for randomized controlled trials up until June 2016. Random effect models were
used to assess the effect of MTI on clinical outcomes as well as adherence to preventer medication or symptom monitoring. Mixed
effects models assessed whether the features of the MTI (ie, use of BCT) and how often a person engaged with MTI moderated
the effects of MTI.
Results: The literature search located 11 studies meeting the inclusion criteria, with 9 providing satisfactory data for meta-analysis.
Compared with standard treatment, MTI had moderate to large effect sizes (Hedges g) on medication adherence and clinical
outcomes. MTI had no additional effects on adherence or clinical outcomes when compared with paper-based monitoring. No
moderator effects were found, and the number of studies was small. A narrative review of the two studies, which are not included
in the meta-analysis, found similar results.
Conclusions: This review indicated the efficacy of MTI for self-management in individuals with asthma and also indicated that
MTI appears to be as efficacious as paper-based monitoring. This review also suggested a need for robust studies to examine the
effects of BCT use and engagement on MTI efficacy to inform the evidence base for MTI in individuals with asthma.
(JMIR Mhealth Uhealth 2017;5(5):e57)   doi:10.2196/mhealth.7168
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Introduction
Background
Asthma is a chronic inflammatory disease of the airways that
is characterized physiologically by excessive variation in airflow
and manifests symptomatically as repeated episodes of coughing,
wheezing, shortness of breath, and chest tightness [1]. Asthma
affects 2.5 million Australians (11%) across the lifespan [2].
In terms of treatment recommendations, the National Asthma
Council Australia and Global Strategy for Asthma Management
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and Prevention have recommended the use of personalized
action plans and daily preventer medications to manage the
illness [1,3]. Action plans are associated with improved clinical
outcomes through incorporation of appropriate education,
self-monitoring of symptoms and medication use, and review
of symptoms by the individual between physician visits [4]. In
more severe patients, daily preventer treatment is associated
with a reduced risk of death, as well as asthma exacerbations,
thus requiring hospitalization or oral steroid with their related
side effects [5,6].
Despite current guidelines recommending action plans and daily
preventer medication, patients’ actual adherence to either
treatment remains low. In 2015, only 28.10% (702,500/
2,500,000) of Australians with asthma had an action plan [2].
Similarly, medication adherence is also suboptimal, with only
59.63% (1601/2685) of those with asthma reported using
preventer medication at least once within a 12-month period,
and only 33.89% (910/2685) reporting daily use [6]. Objective
data on the dispensing of prescriptions for asthma preventer
medication indicate that less than 18.00% (253,123/1,406,240)
of those with asthma use preventer medication daily [7]. A
longitudinal study following middle-aged adults with asthma
over 12 months found that 73.8% (259/351) used inadequate
preventer medication [8]. This is concerning, as research
suggests that appropriate use of preventer medication could
protect against progressive decline in lung function, which is
associated with increasing asthma severity [8].
Lower adherence is associated with individuals who perceive
their asthma to be an acute condition with few adverse personal
consequences and thus has a lower perceived necessity for the
preventer treatment [9]. The Common Sense Model of Illness
[10] provides a theoretical explanation for asthma nonadherence.
Information provided to the individual should inform perceptions
of the causes, consequences, controllability, identity, and
timeline of asthma, which drive coping responses around
adherence, management, and so on. This in turn should as a
consequence have positive effects on clinical outcomes, that is,
exacerbation rates, hospitalizations, and so on [10].
Mobile Technology Interventions
Mobile technology interventions (MTI) can provide an external
source of self-management support, allow for accurate real-time
symptom and medication monitoring, and use built-in reminders
to adhere to treatment, as well as can store and activate action
plans. Studies suggest that over 80% of people with asthma are
willing to use MTI, and quantitative studies suggest that it is an
acceptable medium for assisting asthma self-management
[11,12]. This might be facilitated by MTI providing a feeling
of support that positively influences individuals’ ability to cope
with their asthma [13], for example, by identifying
asthma-related stressors [11]. It is also suggested that MTI may
improve the quality of care and asthma-management skills as
well as allow for greater understanding of client attitudes,
interpretation, and misconceptions of their asthma management
[14]. Further, MTI have shown positive short-term behavioral
outcomes for self-management medication in diabetes and for
antiretroviral therapy [15]. However, physicians have
highlighted major concerns to MTI use including increased time
and resource demands, accuracy of information, liability, and
patient confidentiality [14].
Research on behavioral interventions suggests that emphasizing
specific behavior change techniques (BCT) in MTI allows
clearly defined objectives for intervention development and
therefore improved replication [16]. A recent review of mobile
intervention applications for medication adherence found that
action plans, prompt or cues, self-monitoring, and feedback on
behavior were the most commonly used BCT, but at the same
time that most recent mobile applications made limited or no
use of BCT [17]. Using BCT in MTI has several advantages:
As observable working components of MTI, BCT allow for
replication and creation of a sustainable evidence
base—basically, it becomes easier to compare MTI efficacy
based on their contents and develop more effective MTI on this
evidence base. Further, the theoretical underpinning of BCT
allows understanding and identifying the mechanisms of change
in adherence behavior and informs future improved MTI
development [16]. BCT can therefore increase the likelihood
of MTI efficacy to improve medication adherence [17], in
particular, if they are being deployed within a well-functioning
health care provider-patient relationship [11], and the BCT align
with the therapeutic approach to self-management. Currently,
it is unclear to what degree MTI for asthma management apply
evidence-based BCT or provide evidence-based content.
Behaviour change techniques, including action plans,
self-monitoring, and feedback on behavior, may be unsuccessful
unless the individual engages with the MTI. Engagement with
the MTI is in itself a quantifiable measure, ie, how often the
individual sends or responds to the MTI [18], and indeed the
efficacy of the MTI is likely to be dependent on the active
engagement of the individual [19]. However, the reporting of
such engagement with MTI has been poor, and engagement
appears to be widely variable [18].
MTI in Asthma: The Present Review
There have been two reviews of MTI in asthma
self-management. Belisario and colleagues [20] conducted a
systematic review and meta-analysis of two MTI of asthma
self-management and found insufficient evidence to draw a
conclusion. Tran and colleagues [21] conducted a systematic
review of 6 MTI of asthma self-management and found MTI
was associated with greater medication adherence compared
with standard treatment, but this did not translate to
improvements in quality of life, symptom control, or lung
function. These studies highlighted the need to identify studies
that included evidence-based techniques of MTI, which
successfully instigated changes and sustainability of
self-management behavior.
Aims of This Review
This study therefore aimed to investigate the efficacy of MTI
for adherence (medication and self-monitoring) and clinical
health outcomes (lung function, quality of life, asthma control,
and unscheduled visits) in individuals with asthma. In addition,
we conducted explanatory analyses to answer the following
important theoretical and applied research questions: (1) Is MTI
more efficacious than standard treatment or paper-based
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monitoring? (2) What behaviour change techniques are effective
via mobile technology interventionsI? (3) Does engagement
with the MTI enhance outcomes?
Methods
Literature Search, Inclusion Criteria, and Study
Selection
This review adheres to the Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA, [22]). A
systematic literature review was conducted using Medical
Literature Analysis and Retrieval System Online (MEDLINE),
PsychNet, Scopus, and Web of Science to collect published
studies as well as ProQuest Dissertations and Theses Global
and ClinicalTrials.gov for relevant trials or unpublished studies.
In addition, the reference lists of included studies and applicable
systematic reviews were hand searched to identify additional
studies. Titles, abstracts, and keywords were used to identify
relevant studies (refer to Multimedia Appendix 1 for the full
search strategy).
We included any randomized controlled trial using an MTI
where the primary target of the MTI was the individual with
asthma. Therefore, trials with children were excluded if the
parent was responsible for asthma management. MTI were
included if they used any mobile device that was currently
available (ie, smart phone, tablet, or mobile phone) and any
platform of delivery that incorporated at least one target behavior
(ie, text message, application, music file). Papers not written in
English were excluded. Screening individuals with asthma can
result in improved asthma control over the proceeding week
[23]. Therefore, to ensure that any changes in outcomes were
due to the MTI, only the papers that exceeded the study duration
of 1 month were included. The search was completed on the
June 30, 2016, with the identification of 61 potential studies.
Full texts of all eligible studies were retrieved and assessed
against the inclusion criteria by LM and reviewed through
discussion with BS. There were 11 studies included in the
systematic review, with 9 included in the meta‐analysis, on the
basis of sufficient data. A flowchart of the study selection
process can be found in Figure 1. The studies excluded from
the full-text review and their reasons for omission can be found
in Multimedia Appendix 2.
Study Characteristics
For each study, we extracted publication characteristics (eg,
year of publication), the study design (eg, type of intervention,
MTI characteristics), the sample (eg, female percentage, mean
age, asthma severity), and the outcome variables (eg, adherence,
symptom monitoring, lung function, quality of life) at pre- and
postintervention or at change between pre- and postintervention
time points. Data from the end point were taken for those studies
reporting data over multiple times. A complete list of the
extracted characteristics from all the identified studies included
in the meta-analysis and the narrative review can be found in
Multimedia Appendix 3.
Figure 1. Flowchart of the study selection process for the systematic review and meta-analysis.
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Classification of BCT
None of the included studies specifically mentioned any
behaviour change technique. We used the behavior change
technology taxonomy [16] to code the features of the MTI. This
taxonomy identifies 93 distinct and evidenced-based techniques
within 16 categories of behavior-change interventions. The
features of any paper-based monitoring and standard treatment
groups were also classified according to the taxonomy for each
of the included studies.
Risk of Bias Assessment
The quality of the included manuscripts was assessed according
to the Cochrane Risk of Bias Guidelines [24]. The Cochrane
Risk of Bias dimensions included random sequence generation,
allocation concealment, blinding of outcome assessment,
incomplete outcome data, selective reporting, and other bias
[24]. The option of “blinding participants and personnel” was
excluded because participants could not be blinded as to whether
they did or did not receive the MTI. LM assessed the risk of
bias in the included studies, which was reviewed through
discussion with BS. Each domain was judged as “low,” “high,”
or “unclear.”
Primary and Secondary Outcomes
The primary outcomes were clinical health markers (ie, lung
function, quality of life, asthma control, and unscheduled visits
to the general physician or the emergency department) as well
as frequency of self-monitoring and medication behaviors
(adherence). Secondary outcomes were the type and number of
behaviour change technique used and the frequency of mobile
technology intervention use (engagement) .
Meta-Analytic Strategy
The most frequently reported effects were postintervention
unstandardized means and standard deviations, or change from,
and therefore Hedges g was the effect measure used for the
meta‐analysis. If available, change data were used in preference
to postintervention data, as change scores provide a more
powerful estimate of the intervention effect [24]. Bias-corrected
Hedges g was reported to account for the positively biased
estimate of an effect size when sample sizes are small, which
was common in the included studies [25].
The meta-analytic procedure was conducted using the R
“metafor” package [26] applying a random effects model on
pooled effect sizes of primary and secondary outcomes. The
assumption of the random effects model is that variability
between effect sizes is due to real between-study differences
and allows for generalizability of findings beyond the included
studies [27]. It was hypothesized that studies in the meta-analysis
would provide multiple effect sizes because different outcome
variables were being assessed. The magnitude of the effect was
interpreted as small (0.20), moderate (0.50), and large (0.80)
[25].
Heterogeneity of effect sizes was measured using Q and
I2statistics. Caution should be taken when interpreting these
statistics as they are often imprecisely estimated in the presence
of a small number of studies, as in this meta-analysis [24].
Funnel plots were visually examined to assess for publication
bias. No tests of funnel plot asymmetry were conducted due to
the small power of the test in a small sample of studies [24].
Mixed-effects meta-analysis was used to perform the categorical
and continuous moderation analyses. Due to overlap in BCT
between MTI and paper-based monitoring, only studies
comparing MTI with standard treatment were included in the
BCT moderation analyses. BCT were aggregated to 4 categorical
variables (self-monitoring with feedback, self-monitoring only,
prompting only, other) and were entered as categorical
moderators. All relevant behavior change technique taxonomies
(BCTT), with the exception of “Instruction on how to perform
the behavior” (BCTT 4.1) and “Information about health
consequences” (BCTT 5.1), contributed to the number of BCTT
in the MTI group. Behavior change technique taxonomies 4.1
and 5.1 were excluded as they were also commonly used in the
standard treatment group.
A categorical moderation analysis was used to assess the within-
and between-group variability of effect sizes using a
dummy-coded categorical factor to indicate the moderators.
Categorical moderation is indicated by a significant
between-group statistic (QM).
The numbers of BCT used in MTI and engagement with MTI
were entered as continuous moderators for the effect size
estimates, and the standardized regression coefficient of the
moderator was examined for statistical significance. In addition,
the R2statistic indicates how much of the variation between
studies can be explained by the model containing the moderator,
relative to the total variation.
Results
Study Characteristics
Table 1 shows the population characteristics of the included
studies. The mean sample size of 11 included studies was 103,
ranging from 16 to 288. The mean study duration was 17 weeks,
ranging from 12 to 24 weeks. The age of participants ranged
from 10 years to about 65 years, with a mean age of 34 years,
and the percentage of female participants was 61.1% (583/954).
Asthma severity varied from mild to severe persistent asthma,
but the method used to assess this was reported only in 5 studies
[28-32].
The effect sizes for MTI were computed from comparisons of
MTI with paper-based and standard treatment. Three studies
compared MTI with paper-based [29,31,32], one with
paper-based as well as standard treatment [30], and the
remaining studies compared MTI with standard treatment.
Four studies used MTI with a mobile app platform (MTI-App)
and the remaining 7 used MTI with a short message service
platform (MTI-SMS). Interactivity, that is, how often the person
sent or received content from the MTI, ranged from daily to
weekly, with daily being the most common (55%, 6/11) followed
by twice daily (36%, 4/11). Seven of the studies used tailoring
in the form of feedback based on individuals’ symptoms [28-34].
One study sent tailored SMS based on faulty illness perceptions
[35]. Four studies explicitly stated the application of behavior
change theories when designing their MTI [32,35-37]. These
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included the Health Belief Model [38], Illness Perceptions for
Adherence [39], and Monitoring in Chronic Disease [40]. Seven
studies did not report a theoretical model for their MTI
[28-31,33,34,41].
Table 1. Study population characteristics of included studies.
Asthma severityFemale %Mean age in years (range)N (Duration in weeks)CountryYearLead author
Moderate (?a)44 (7/16)25 (18+)16 (16)Croatia2005Ostojic [31]
Moderate to severe (?)51 (45/89)52 (18+)120 (24)Taiwan2007Liu [29]
Poorly controlled (94%)59.2 (71/120)55 (21+)120 (12)Singapore2010Prabhakaran [33]
Moderate to severe (69%)46 (12/26)32 (18-45)26 (12)Denmark2010Strandbygaard [41]
Moderate to severe (73%)42 (30/71)38 (18-65)150 (12)China2012Lv [30]
Nonadherence (100%)68.0 (100/147)? (16-45)147 (18)UK2012Petrie [35]
Poorly controlled (100%)62.5 (180/288)49 (12+)288 (24)UK2012Ryan [32]
Moderate to severe (?)47 (7/15)14 (10-16)30 (15)USA2012Yun [37]
Moderate to severe (?)57 (12/21)13 (10-16)30 (16)USA2013Yun [36]
Mild to severe (?)53 (47/89)33 (25-41)136 (12)Turkey2015Cingi [28]
Moderate to severe (58%)100 (72/72)31 (18+)72 (24)Australia2016Zairina [34]
aValue could not be identified in the study.
Classification of BCT
There were 10 distinct behaviour change techniques identified
within the included studies across 8 categories (Tables 2 and 3)
“Instruction on how to monitor symptoms and medication” as
well as “Information on health consequences” appeared to
represent the standard education provided to asthma participants
as part of their standard treatment and was used across all
groups. All MTI-App used self-monitoring of symptoms or
medication, compared with 44% (4/9) of MTI-SMS. Prompt or
cues were used in 78% (7/9) of MTI-SMS compared with 25%
(1/4) of MTI-App. Action planning was a lot more common in
MTI-App (75%, 3/4) than MTI-SMS (11%, 1/9). Paper-based
monitoring utilized similar BCT as MTI-App but did not provide
feedback or social support from an external source. “Feedback”
was categorized as individuals receiving feedback based on
their symptoms or medication being monitored. “Social support”
(practical) differed from feedback, as the participant could send
a message to their physician or the investigators for responses
to questions they had.
Table 2. Classification of behavior change technique taxonomy for each included study.
Comparator TypeMTIMTIaPlatformYearLead author
Paper-based: 2.3; 4.1; 5.12.3; 2.6; 2.7; 3.2; 4.1; 5.1MTI-SMSb2005Ostojic [31]
Paper-based: 1.4; 2.3; 2.6; 4.1; 5.11.4; 2.3; 2.6; 4.1; 5.1MTI-Appc2007Liu [29]
Standard treatment: 4.12.3; 2.7; 3.2; 4.1; 7.1MTI-SMS2010Prabhakaran [33]
Standard treatment: 4.1; 5.14.1; 5.1; 7.1MTI-SMS2010Strandbygaard [41]
Paper-based: 1.4; 2.3; 4.1; 5.1
Standard treatment: 4.1; 5.1
1.4; 3.2; 4.1; 5.1; 7.1MTI-SMS2012Lv [30]
Standard treatment: ?4.2; 5.1MTI-SMS2012Petrie [35]
Paper-based: 1.4; 2.3; 4.1; 6.11.4; 2.3; 2.7; 3.2; 4.1; 5.1; 6.1MTI-App2012Ryan [32]
MTI: 2.3; 7.1
Standard treatment: ?
2.3; 2.7; 5.1; 7.1MTI-SMS2012Yun [37]
MTI: 5.1; 7.1
Standard treatment: ?
2.3; 2.7; 5.1; 7.1MTI-SMS2013Yun [36]
Standard treatment: 4.12.3; 3.2; 4.1; 7.1MTI-App2015Cingi [28]
Standard treatment: 5.11.4; 2.3; 2.7; 3.2; 5.1MTI-App2016Zairina [34]
aMTI: Mobile technology interventions.
bMTI-SMS: Mobile technology interventions with short message service platform.
cMTI-App: Mobile technology interventions with mobile app platform.
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Table 3. Behavior change technique taxonomy used by study group.
Standard treatment
n (%) (N=8)
Paper-based
n (%) (N=4)
MTIc-All
n (%) (N=13)
MTI-SMSb
n (%) (N=9)
MTI-Appa
n (%) (N=4)
Behavior change technique taxonomy
0 (0%)3 (75%)4 (31%)1 (11%)3 (75%)1.4 Action planning
0 (0%)4 (100%)8 (62%)4 (44%)4 (100%)2.3 Self-monitoring of behavior
0 (0%)1 (25%)2 (15%)1 (11%)1 (25%)2.6 Biofeedback
0 (0%)0 (0%)6 (46%)4 (44%)2 (50%)2.7 Feedback on outcomes of behavior
0 (0%)0 (0%)5 (46%)3 (33%)3 (75%)3.2 Social support (practical)
4 (50%)4 (100%)7 (54%)4 (44%)3 (75%)4.1 Instruction on how to perform the behavior
0 (0%)0 (0%)1 (8%)1 (11%)0 (0%)4.2 Information about antecedents
3 (38%)3 (75%)11 (85%)8 (89%)3 (75%)5.1 Information about health consequences
0 (0%)1 (25%)1 (8%)0 (0%)1 (25%)6.1 Demonstration of the behavior
0 (0%)0 (0%)8 (62%)7 (78%)1 (25%)7.1 Prompts or cues
aMTI-App: Mobile technology interventions with mobile app platform.
bMTI-SMS: Mobile technology interventions with short message service platform.
cMTI: Mobile technology interventions.
Risk of Bias Assessment
The results of the Cochrane Risk of Bias assessment are shown
in Figures 2 and 3, with complete details presented in
Multimedia Appendix 4.
Seven studies reported using appropriate random sequence
generation methods (computer-generated random allocation,
random order on presentation, or drawn from envelope); 4
studies did not specify the method of randomization
[29,30,36,37]. Three studies reported concealment of allocation
[32,34,35]. The remaining 8 studies were unclear as to whether
allocation was concealed. Only 2 studies addressed blinding of
participants and outcome assessors [32,34]. Although not stated,
we assume that the remaining 9 studies did not carry out blinding
of participants or outcome assessors.
Six of the studies had high risk of incomplete outcome data,
due to varying rates of dropout or missing data between the
groups [28,30,34,36], or because those who dropped out had
higher medication adherence [35] or dropped out due to
difficulty with MTI [29]. In one study, all participants completed
the study [31], and the remaining 4 studies had low and similar
dropout rates between the groups. One study provided a study
protocol, which inferred low risk of selective reporting [34].
The remaining studies were unclear on potential selective
reporting, but relevant variables appeared to be reported. No
other potential sources of bias were identified. Overall the risk
profile was quite reasonable.
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Figure 2. Cochrane risk of bias assessment: risk of bias dimension for each included study.
Figure 3. Cochrane risk of bias assessment: summary of each risk of bias item.
Clinical Outcomes
The studies reported adherence to medication as well as
symptoms or diary entries over a time period between 12 and
24 weeks. Adherence was assessed either via prescription data
or self-report throughout the intervention or at the end of the
study. Four studies reported percentage adherence to preventer
medication at end of study [30,32,35] or change over the study
period [41]. The remaining two provided average inhaled
cortico-steroid dosage at the end of study [29,31] . Two studies
reported percentage adherence at end of study to symptom
monitoring and action plan [29] and peak expiratory flow rate
monitoring [31].
Five studies provided data on lung function in the form of mean
Forced Expiratory Volume in 1 second predicted at end of the
study [29,32] or change over the study period [30,34,41]. Four
studies provided data on change in Quality of Life (QoL) over
the study period, using the full or mini version of the
Asthma-Specific Quality of Life Questionnaire [30,32,34,41].
One study provided mean scores, at the end of the study period
only, using the Short-Form-12 Questionnaire—Physical
Component Score [29]. Four studies provided data on change
in asthma control over the study period, using the Asthma
Control Questionnaire [32,34,41] and the Perceived Control of
Asthma Questionnaire [30]. Three studies provided the
percentage of individuals with well-controlled asthma at end of
the study [28,33,34], while 6 studies reported the percentage of
unscheduled visits at end of the study [28-33].
Five studies provided the mean percentage of engagement,
which ranged from 72% to 99% [29,31,33,36,37]. Three studies
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did not provided data on engagement with the MTI [32,34] or
only median data were available [28]. A further two studies
[30,41] did not have adequate engagement data as the MTI
incorporated an SMS prompt that did not require engagement
with the system.
MTI Effectiveness by Adherence and Health Outcome
Table 4 shows the effect of MTI on adherence based on the
random effects model. Tests of heterogeneity suggested low
variation among the true effects between the remaining studies.
However, the width of the confidence intervals suggests an
imprecise estimate of heterogeneity and caution should be taken
when interpreting these results.
There was no evidence for a difference in the standardized mean
medication adherence or symptom-monitoring adherence in
studies comparing MTI with paper-based (Figures 4 and 5,
respectively). Individuals using MTI had a significantly higher
standardized mean medication adherence compared with
standard treatment (Figure 6), suggesting a moderate positive
effect.
Table 5 shows the effect of MTI on clinical outcomes based on
the random effects model. Test of heterogeneity suggested high
variation in asthma control between MTI and standard treatment
studies as well as in unscheduled visits between MTI and
paper-based studies. There was moderate to low variation among
the true effects between the remaining studies, but the width of
the confidence intervals suggests an imprecise estimate of
heterogeneity and caution should be taken when interpreting
these results.
There was no evidence for a difference in mean lung function,
QoL, asthma control, or percentage of unscheduled visits in
studies comparing MTI with paper-based monitoring (Figures
7-10). Similarly, there was no evidence for a difference in mean
lung function or asthma control in studies comparing MTI with
standard treatment (Figures 11 and 12, respectively). However,
there was evidence for a significantly higher standardized mean
QoL as well as lower mean percentage of unscheduled visits
and more well-controlled asthma in studies comparing MTI
with standard treatment (Figures 13-15)
Table 4. Hedges g and tests of heterogeneity of mobile technology intervention (MTI) for adherence.
I2g(95% CI)P fQ eP dHedges g (95%CIc)Nbk aAdherence
MTI vs Paper-based
<.01 (<.01-72.42).781.08.100.16 (-0.03 to 0.34)4504Medication
<.01 (<.01-99.55).640.22.51-0.11 (-0.45 to 0.22)1362Symptoms
MTI vs Standard treatment
<.01 (<.01-89.65).770.53<.0010.63 (0.31 - 0.94)1693Medication
aNumber of studies.
bTotal sample size across included studies.
c95% CIs around the Hedges g effect size.
dP value of Hedges g effect size.
eTest of heterogeneity.
fP value of test for heterogeneity.
gPercentage of total variability due to heterogeneity.
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Table 5. Hedges g and tests of heterogeneity of mobile technology intervention (MTI) for clinical outcomes.
I2g(95% CI)P fQ eP dHedges g (95%CIc)Nbk aOutcome
MTI vs Paper-based
41.63 (<.01- 97.54).213.1.480.16 (-0.28 to 0.60)1623Lung function
67.93 (<.01-99.04).036.79.120.33 (-0.08 to 0.74)3473QoLh
55.28 (<.01-99.56).142.24.460.16 (−0.26 to 0.57)3352Asthma control
90.51 (67.49-99.4)<.00135.5.21-0.49 (-1.26 to 0.27)4434Unscheduled visits
MTI vs Standard Treatment
46.15 (<.01-99.07).153.84.380.23 (-0.28 to 0.73)1333Lung function
31.33 (<.01-98.88).193.29.010.64 (0.19 - 1.08)1333QoLh
81.27 (33.23-99.50).00211.79>.990.00 (-0.87 to 0.87)1333Asthma control
<.01 (<.01-96.19).491.43<.0010.45 (0.20 - 0.69)2733Well controlled
<.01 (<.01-94.57).720.66<.001-0.64 (-0.90, to 0.38)2483Unscheduled visits
aNumber of studies.
bTotal sample size across included studies.
c95% CIs around the hedges g effect size.
dP value of Hedges g effect size.
eTest of heterogeneity.
fP value of test for heterogeneity.
gPercentage of total variability due to heterogeneity.
hQoL: Quality of Life.
Figure 4. Forest plot of the standardized mean difference in medication adherence between MTI and Paper-based group (PB). MTI: mobile technology
intervention.
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Figure 5. Forest plot of the standardized mean difference in symptom or diary adherence between MTI and paper-based group (PB). MTI: mobile
technology intervention.
Figure 6. Forest plot of the standardized mean difference in medication adherence between MTI and standard treatment group. MTI: mobile technology
intervention.
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Figure 7. Forest plot of the standardized mean difference in lung function between MTI and paper-based group. MTI: mobile technology intervention.
Figure 8. Forest plot of the standardized mean difference in quality of life between MTI and paper-based group (PB). MTI: mobile technology
intervention.
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Figure 9. Forest plot of the standardized mean difference in asthma control between MTI and paper-based group (PB). MTI: mobile technology
intervention.
Figure 10. Forest plot of the standardized mean difference in unscheduled visits between MTI and paper-based group. MTI: mobile technology
intervention.
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Figure 11. Forest plot of the standardized mean difference in lung function between MTI and standard treatment. MTI: mobile technology intervention.
Figure 12. Forest plot of the standardized mean difference in asthma control between MTI and standard treatment. MTI: mobile technology intervention.
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Figure 13. Forest plot of the standardized mean difference in quality of life between MTI and standard treatment. MTI: mobile technology intervention.
Figure 14. Forest plot of the standardized mean difference in well controlled asthma between MTI and standard treatment. MTI: mobile technology
intervention.
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Figure 15. Forest plot of the standardized mean difference in unscheduled visits between MTI and standard treatment. MTI: mobile technology
intervention.
MTI and Publication Bias: Funnel Plots
Across the relationships, symmetry of funnel plots was difficult
to assess due to the small number of studies (ranging from N=2
-6, mean = 3). The number of studies falling outside of the
funnel varied from 0 to 2 (refer to Multimedia Appendix 5 for
funnel plots). Two of the 4 relationships with studies outside
of the funnel (unscheduled visits between MTI and paper-based
as well as asthma control between MTI and standard treatment)
also had high heterogeneity, indicating that moderators may be
present.
Moderation of BCT on Adherence and Clinical
Outcomes
Tables 6-8 show the results of the moderator analyses. Overall,
there was not adequate evidence to determine the type or number
of BCT as moderators of adherence or clinical outcomes in
studies comparing MTI with standard treatment. However,
although the effect of number of BCT used did not reach
statistical significance, it did fully explain the variation in QoL.
Table 6. Categorical moderation analysis for within group behavior change technique (BCT) type on relationship between mobile technology intervention,
adherence, and clinical outcomes.
P bHedges g (95%CI)k aBCT TypeOutcome
.0070.54 (0.15-0.94)1OtherAdherence
.0040.78 (0.25-1.30)2Prompt Only
.710.26 (−1.10-1.62)1Monitor + feedbackLung Function
.780.17 (−0.62 to 0.97)2Prompt Only
.150.81 (−0.31 to 1.91)1Monitor + feedbackQoLc
.300.46 (−0.42 to 1.34)2Prompt Only
.40-0.59 (−1.95 to 0.77)1Monitor + feedbackAsthma Control
.510.35 (−0.7 to 1.39)2Prompt Only
.010.43 (0.09-0.77)2Monitor + feedbackWell Controlled
.050.52 (−0.52 to 0.70)1Monitor Only
aNumber of studies.
bP value of Hedges g effect size.
cQoL: Quality of Life.
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Table 7. Categorical moderation analysis for between group behavior change technique (BCT) type on relationship between mobile technology
intervention, adherence, and clinical outcomes.
I2(95% CI)fOther moderatorsBCT Typek aOutcome
P eQE dP cQM b
<.01 (<.01-97.92).830.05.490.483Adherence
73.98 (<.01-99.85).053.84.900.023Lung function
63.29 (<.01-99.85).102.72.630.233QoLg
73.80, (<.01-99.85).053.82.291.143Asthma control
23.07 (<.01-99.92).251.30.780.083Well controlled
3Unscheduled visitsh
aNumber of studies.
bOmnibus test of moderator (BCT Type).
cP value of test of moderator (BCT Type).
dOmnibus Test of other moderators not considered in model.
eP value of test for other moderators.
fPercentage of total variability due to heterogeneity.
gQoL: Quality of Life.
hMixed effects model would not fit as there was only one study per BCT Type, in the analysis.
Table 8. Continuous moderation analysis for number of behavior change technique (BCT) on relationship between mobile technology intervention,
adherence, and clinical outcomes.
I2(95% CI)gTest for other moderatorsTest of BCTTb#Hedges g (95%CI)k aOutcome
P fQE eR dP c
<.01 (<.01-99.75).530.40NA.720.07 (−0.30 to 0.44)3Adherence
58.14 (<.01->99.90).122.39.00.320.24 (−0.23 to 0.72)3Lung Function
<0.01 (<.01-99.87).390.73100.110.26 (−0.026 to 0.59)3QoLh
90.61 (52.83-99.80).00110.65.00.93−0.04 (−1.01 to 0.92)3Asthma Control
23.07 (<.01-99.92).251.30NA.78−0.09 (−0.70 to 0.52)3Well Controlled
<.01 (<.01-99.85).420.64NA.90−0.03 (−0.56 to 0.49)3Unscheduled Visits
aNumber of studies.
bBCTT: Behavior change technique taxonomy
cP value of Hedges g effect size.
dAmount of variation explained by the moderator.
eOmnibus Test of other moderators not considered in model.
fP value of test for other moderators.
gPercentage of total variability due to heterogeneity.
hQoL: Quality of Life.
Moderation of Engagement on Adherence and Clinical
Outcomes
Only 1 study provided data on engagement for studies
comparing MTI with standard treatment [33], and 2 studies
comparing MTI with paper-based monitoring [29,31]. Therefore,
there were insufficient data to determine if engagement was a
moderator between MTI and adherence or clinical outcomes.
However, there were sufficient data to test the effect of MTI on
attrition using a random effects model, although caution is
needed as this was a secondary analysis not included in the
initial plan. For what it is worth, there was no evidence for a
difference in the standardized mean attrition in studies when
comparing MTI with paper-based monitoring and standard
treatment (Multimedia Appendix 6).
Narrative Review
A narrative review was undertaken on the 2 studies that had
insufficient data for the meta‐analysis (refer to Multimedia
Appendix 3 for the study characteristics). Both studies examined
the effect of MTI on improving lung function and quality of life
compared with standard treatment [36,37]. Consistent with
findings from the meta-analysis, 1 of the 2 studies reporting on
QoL found higher levels using MTI compared with standard
treatment [36]. Unlike the findings of the meta-analysis, both
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studies reported on lung function and found improved levels
using MTI compared with standard treatment [36,37].
Discussion
Principal Findings
The aim of this systematic review and meta-analysis was to
determine the efficacy of MTI for asthma self-management.
The findings support the effects of MTI for improving adherence
and clinical outcomes in asthma [15,21] if compared with
standard treatment. Furthermore, these results are consistent
with the relationship between MTI, adherence, and clinical
outcomes in chronic illness [15] and provide an evidence base
for the content of MTI. However, more research is required to
determine the role of BCT and engagement in MTI.
The current review found that MTI had a moderate effect on
improving medication adherence when compared with standard
treatment. Further, the current review suggests that MTI indeed
do have a large effect on improving QoL and a moderate effect
on individuals achieving well-controlled asthma and fewer
unscheduled visits. This is in contrast to previous findings by
Tran and colleagues [21] that MTI does not improve clinical
outcomes. Consistent with their findings, this review found no
evidence of a difference in mean lung function. In addition, the
findings in this review are consistent with previous research on
chronic illnesses in general that found positive changes in
clinical outcomes when using MTI [15], as well as a positive
association between medication adherence and improved clinical
outcomes for individuals with asthma [5].
Although study duration was identified as a potential limitation
to finding change in clinical outcomes [21], the current review
noted similar duration in all studies, of around 3 months. The
current findings are an advance on previous attempts at
systematic reviews of MTI, as it features increased power due
to more included studies and by excluding interventions based
on telephone-call monitoring, thereby showing clearer effects
of MTI. The findings also support claims by physicians working
with individuals with asthma who proposed that MTI would
improve the quality of care [14]. However, longer duration
studies would certainly be valuable. Clinically relevant
improvements in QoL, asthma control, and lung function
between 3 and 12 months have been found when using
Internet-based self-management of asthma compared with
standard treatment over 12 months [42], which suggests
extending the duration of MTI studies. Furthermore,
improvements in QoL and asthma control from Internet-based
self-management have been sustained for up to 1.5 years after
support has ceased [43].
However, a different picture emerges when MTI effects are
compared with paper-based monitoring. Here, the current review
found no evidence of a difference in medication or symptom or
diary adherence or clinical outcomes.
This suggests 2 indirect conclusions: First, given MTI resulted
in improved adherence and clinical outcomes over standard
treatment, it suggests that providing instruction on behavior and
information about health consequences in itself is not sufficient
to improve adherence and consequent health benefits in
individuals with asthma. This is consistent with previous
findings of a similar improvement in asthma knowledge and
inhalation technique between Internet-based self-management
and standard treatment over 12 months, concluding that baseline
meetings can trigger improvements in these areas without the
need for further education [42]. Second, given that there was
no difference between MTI and paper-based monitoring, it could
suggest improvements in medication adherence and clinical
outcomes can be made by providing some feature to monitor
medication or symptoms in either electronic or conventional
paper form.
As in previous reviews [18], only few of the included studies
reported engagement, and when reported at all was widely
variable. There was insufficient detail to undertake a formal
analysis of engagement, and a secondary analysis looking at
individual dropout from the study found no evidence of a
difference between MTI and paper-based or standard treatment.
However, as MTI are probably an acceptable medium, the fact
that they are more portable and potentially more accurate than
a paper diary [11-13] points to their potential to help people
manage and cope with their asthma.
Limitations and Future Research
Similar to previous reviews supporting the efficacy of MTI in
supporting self-management of chronic illnesses in general [15],
this review provides strong evidence for at least short-term
efficacy of MTI for asthma management. This supports the need
for longer duration studies to identify not just efficacy, but also
cost effectiveness, client and physician safety, and the specific
constituent behaviour change techniques within the mobile
technology intervention that really matters most. Consistent
with previous research [15], there was much variation in the
study designs and intervention characteristics in this review,
making it difficult to draw clear associations between the
individual effects of the MTI, the specific study design, and
included BCT.
Concerning study quality, small sample size and poor
recruitment appear to be a consistent issue in research on MTI
and may lead to a lack of generalizability of findings to the
broader asthma population [15]. The asthma population varies
in regard to asthma severity, health literacy, ability for
self-management, and preference for mobile management [44],
which makes generalizing findings from single studies and even
reviews difficult. The exclusion of individuals with
comorbidities also needs addressing as these are frequent in
older individuals [1], and this may be contributing to the
exclusion of older individuals within MTI research. Furthermore,
as recent research [45] has shown that up to one-third of people
with physician-diagnosed asthma in the past 5 years do not have
current asthma; future treatment evaluations need to establish
current asthma objectively, since treatment is unlikely to be
effective in people without diagnosed current asthma. For this
study, this means that we cannot rule out that people without
diagnosed current asthma received treatment which in turn
showed no effects.
In addition, this review is limited by the degree to which the
included studies reported a theoretical basis for their intervention
and subsequently based their interventions on this theory.
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Internet and mobile-based interventions for promoting
health-behavior change have been found to be more efficacious
when incorporating more extensive use of theory, BCT, and
using text messages as mode of delivery [46]. However, current
MTI often lack a theoretical basis underlying the MTI content
[15]. In this review, less than half of the included studies
provided a theoretical basis for their MTI, and no study specified
the BCT used. Thus, the classification of BCT according to a
current taxonomy [16] is based only on the information provided
in the studies, and we cannot confirm the authors’ original
intention.
Two studies in this review found evidence to support changes
in medication adherence alongside changes in the individual’s
perception of asthma [35,41]. Illness perceptions play a role in
asthma self-management [9], with perceived changes to beliefs
around duration, control, and severity of asthma associated with
the use of MTI with self-monitoring [11,13]. If MTI with
self-monitoring indirectly changes asthma perceptions then this
validates the Common Sense Model of Illness [10] as a
theoretical framework for asthma MTI. Further exploration is
warranted on whether targeting illness perceptions alone is
sufficient for lasting behavior change and highlights the
important related question of defining whom to target with
which behaviour change technique. One of the included studies
found targeting faulty illness perceptions through MTI increased
medication adherence [35]. Paradoxically, this study also found
those with higher adherence were less likely to remain in the
study [35], suggesting that only people with partially or
uncontrolled asthma due to faulty illness perceptions would
benefit from this type of MTI.
Another study found individuals with milder asthma were more
likely to withdraw from paper-based monitoring than standard
treatment or MTI [30]. This may suggest that MTI with
monitoring is more attractive than paper-based in those with
milder severity. Given the current guidelines recommending
action plans for asthma management, an MTI that can store and
activate action plans would be suitable for any level of severity,
but presumably those at most need at the more severe end of
the range. Action plans are most effective at improving clinical
outcomes when two to four action points are included based on
asthma symptoms or peak expiratory flows [4]. The addition of
inhalation devices to electronic monitoring devices, perhaps via
Bluetooth, has been proposed to record inhalation use data as
well as inhalation technique [44]. However, increasing the
complexity of the mobile app will also lead to increases in cost
and risk to the individual with asthma and the physician, if not
adequately tested [44,47].
Perhaps the main limitation of this review was the small number
of included studies, which meant that the power of the tests was
relatively low, with a high chance of Type-2 statistical errors
[24]. On the other hand, the fact that differences were found at
all indicates stable effects. Tests of heterogeneity and effect
sizes both produced large confidence intervals, again reflecting
imprecise estimates. Furthermore, tests of publication bias could
not be performed. To validate the findings of this review and
extend the ability to do robust analyses before public use, longer
and larger studies are required that incorporate a theoretical
basis and behavior change techniques [46], and that follow
guidelines for reporting MTI [48].
Implications and Conclusion
MTI for asthma management can improve medication adherence
and quality of life, decrease unscheduled visits, and increase
the likelihood of achieving well-controlled asthma compared
with standard treatment alone. In addition, MTI appear to be
equally as efficacious as paper-based monitoring at achieving
higher medication adherence and clinical outcomes. Better
reporting of BCT and further research into long-term efficacy
of MTI for adherence behavior and clinical outcomes is needed
to create an evidence base for specific behaviour change
techniques that best support individuals with asthma.
Finally, implementation of mobile technology interventions
poses a challenge: Physicians’ concerns regarding increased
time and resource demands, accuracy of information, physician
liability, and patient confidentiality [14] must be addressed.
Furthermore, as MTI are being used to make critical decisions,
they must be tested for accuracy and reliability to reduce harm
to the individual and potential liability for the physician [47].
Increased involvement of the physician in the development and
testing phases of the MTI as well as assessment of privacy
issues, and improvements in regulation and safety checks by
regulatory bodies and the development of a risk assessment
framework for medical mobile app is warranted [44,47].
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